"This return gap is enormous", said Stefano Visalli, director at McKinsey. "It is bigger than the total profits of the global pharmaceutical and automotives industries put together. To achieve this will require a radical break with past trends for an industry that has never before decreased costs in absolute terms; in the next years it may need to reduce them by 15pc-25pc as well as increasing revenues."